Reply: Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. Labeling
- PMID: 28254191
- DOI: 10.1016/j.jacc.2016.11.075
Reply: Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. Labeling
Comment on
-
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.J Am Coll Cardiol. 2016 Sep 27;68(13):1452-1464. doi: 10.1016/j.jacc.2016.06.057. J Am Coll Cardiol. 2016. PMID: 27659468 Review.
-
Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. Labeling.J Am Coll Cardiol. 2017 Mar 7;69(9):1211. doi: 10.1016/j.jacc.2016.11.074. J Am Coll Cardiol. 2017. PMID: 28254190 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical